PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
9.31%
Positive revenue growth while MCHP is negative. John Neff might see a notable competitive edge here.
11.33%
Positive gross profit growth while MCHP is negative. John Neff would see a clear operational edge over the competitor.
14.74%
Positive EBIT growth while MCHP is negative. John Neff might see a substantial edge in operational management.
18.05%
Positive operating income growth while MCHP is negative. John Neff might view this as a competitive edge in operations.
9.84%
Positive net income growth while MCHP is negative. John Neff might see a big relative performance advantage.
10.85%
Positive EPS growth while MCHP is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.
10.16%
Positive diluted EPS growth while MCHP is negative. John Neff might view this as a strong relative advantage in controlling dilution.
-0.22%
Share reduction while MCHP is at 0.00%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-0.44%
Both reduce diluted shares. Martin Whitman would review each firm’s ability to continue repurchases and manage option issuance.
-0.02%
Dividend reduction while MCHP stands at 0.45%. Joel Greenblatt would question the firm’s cash flow stability or capital allocation decisions.
119.08%
Positive OCF growth while MCHP is negative. John Neff would see this as a clear operational advantage vs. the competitor.
302.55%
Positive FCF growth while MCHP is negative. John Neff would see a strong competitive edge in net cash generation.
56.74%
Similar 10Y revenue/share CAGR to MCHP's 59.29%. Walter Schloss might see both firms benefiting from the same long-term demand.
38.54%
Positive 5Y CAGR while MCHP is negative. John Neff might see an underappreciated edge for the firm vs. the competitor.
-13.53%
Both firms have negative 3Y CAGR. Martin Whitman would wonder if the entire market segment is in short-term retreat.
158.33%
Positive long-term OCF/share growth while MCHP is negative. John Neff would see a structural advantage in sustained cash generation.
9.09%
Positive OCF/share growth while MCHP is negative. John Neff might see a comparative advantage in operational cash viability.
6.59%
Positive 3Y OCF/share CAGR while MCHP is negative. John Neff might see a big short-term edge in operational efficiency.
111.90%
Positive 10Y CAGR while MCHP is negative. John Neff might see a substantial advantage in bottom-line trajectory.
-5.33%
Both exhibit negative net income/share growth over five years. Martin Whitman would suspect a challenging environment for the entire niche.
-42.73%
Both companies show negative 3Y net income/share growth. Martin Whitman suspects macro or sector-specific headwinds in the short run.
83.06%
10Y equity/share CAGR at 50-75% of MCHP's 112.95%. Martin Whitman would note a lag in capital accumulation vs. the competitor.
116.48%
5Y equity/share CAGR above 1.5x MCHP's 3.99%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
17.94%
3Y equity/share CAGR 1.25-1.5x MCHP's 13.04%. Bruce Berkowitz confirms timely buybacks or margin improvements drive stronger near-term equity growth.
297.32%
10Y dividend/share CAGR above 1.5x MCHP's 155.03%. David Dodd checks if the firm's robust cash flows justify outpacing the competitor's increases.
51.38%
Below 50% of MCHP's 148.00%. Michael Burry worries the firm returns far less capital to shareholders over 5 years.
18.05%
Below 50% of MCHP's 106.54%. Michael Burry suspects the firm invests elsewhere or can’t match the competitor’s dividend policy.
-36.69%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
2.67%
Inventory growth well above MCHP's 2.42%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
3.48%
Positive asset growth while MCHP is shrinking. John Neff sees potential for us to outgrow the competitor if returns are solid.
0.20%
Positive BV/share change while MCHP is negative. John Neff sees a clear edge over a competitor losing equity.
9.30%
Debt growth far above MCHP's 4.11%. Michael Burry fears the firm is taking on undue leverage vs. the competitor.
1.93%
We increase R&D while MCHP cuts. John Neff sees a short-term profit drag but a potential lead in future innovations.
2.75%
SG&A growth well above MCHP's 4.32%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.